MAPK3 and acute lymphoblastic leukemia: Next, we examined the contribution of ER Oxidoreductin 1 (ERO1), a well-established downstream target of CHOP that mediates Ca2+ release from the ER [23], in the mechanism of Ca2+ mobilization and activation of p-ERK1/2 in pevonedistat-treated ALL cells.